Login
Register
Submit a Paper
Propose a Special lssue
Open Access
ARTICLE
Erectile dysfunction and hypogonadism (low testosterone)
Humber River Regional Hospital, University of Toronto, Toronto, Ontario, Canada
Address correspondence to Dr. Jack Barkin, Chief of Staff,
Humber River Regional Hospital, 960 Lawrence Avenue
West, Suite 404, Toronto, Ontario M6A 3B5 Canada
Canadian Journal of Urology 2011, 18(Suppl.2), 2-7.
Download PDFAbstract
Erectile dysfunction (ED) is one of the earliest signs and markers of present or potential future endothelial dysfunction. One of the causes of ED can be low testosterone levels or hypogonadism. This article describes ways to identify and diagnose patients with ED or hypogonadism, and it offers a plan for treatment of these conditions. The mainstay first-line medical therapies for ED are phosphodiesterase-5 (PDE-5) inhibitors. For patients with symptomatic hypogonadism, testosterone replacement therapy is both safe and effective.Keywords
erectile dysfunction, hypogonadism
Cite This Article
APA Style
Barkin, J. (2011). Erectile dysfunction and hypogonadism (low testosterone). Canadian Journal of Urology, 18(Suppl.2), 2–7.
Vancouver Style
Barkin J. Erectile dysfunction and hypogonadism (low testosterone). Can J Urology. 2011;18(Suppl.2):2–7.
IEEE Style
J. Barkin, “Erectile dysfunction and hypogonadism (low testosterone),” Can. J. Urology, vol. 18, no. Suppl.2, pp. 2–7, 2011.
Copyright © 2011 The Author(s). Published by Tech Science Press.This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Downloads
Citation Tools
